October Pharma
- 95.50 EGP
- -4.50
- -4.50%
October Pharma SAE Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 95.50 |
| Prev. Close | 100.000 |
| Day Range | 95.50 - 95.50 |
| 52WK range | |
| Turnover (M EGP) | 0.00 |
| Volume (M) | 0.00 |
| Number of Trades | 1 |
| Market Cap (M EGP) | 959.70 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 0.00 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
October Pharma targets EGP 135m net profits in 2022
Cairo – Mubasher: The board of October Pharma approved the estimated budget for 2022, expecting a net profit after tax worth EGP 135 million by the...
October Pharma's profit hikes 65% in nine months
Cairo – Mubasher: October Pharma achieved a 65% year-on-year (YoY) increase in its net profits, logging EGP 100.32 million in the first nine...
October Pharma’s Q1 profits leap 402%
Cairo – Mubasher: October Pharma recorded a surge of 402% in net profits to EGP 40.59 million during the first quarter (Q1) of 2021, compared to...
October Pharma's shareholders approve dividends, delay...
Cairo – Mubasher: The ordinary general meeting (OGM) of October Pharma approved a cash dividend of 30% of the capital or EGP 3 per share for 2020.The...
October Pharma profits jump 161% in 2020; dividends,...
Cairo – Mubasher: October Pharma’s net profits for the year 2020 leapt by 161% on an annual basis, driven by lower production costs and expenses,...
